# Study on the Mechanism of Acquired Resistance of Entrectinib

> **NCT07199959** · — · RECRUITING · sponsor: **Fudan University** · enrollment: 38 (estimated)

## Conditions studied

- ROS1 Fusion Positive
- Non Small Cell Lung Cancer

## Interventions

- **PROCEDURE:** venipuncyure
- **DRUG:** Entrectinib

## Key facts

- **NCT ID:** NCT07199959
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-15
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-01
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2025-09-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07199959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07199959, "Study on the Mechanism of Acquired Resistance of Entrectinib". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07199959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*